Herbalife

HLF · NYSE

$13.39−$0.39 (−2.83%)TodayMarket closed ·
Prev close $13.78

About HLF

Herbalife Ltd. is a holding company, which engages in the provision of health and wellness products. The firm sells weight management; targeted nutrition; energy, sports and fitness; and other nutrition products to and through a network of independent members. The firm has two geographical segments: Primary Reporting Segment (North America, Latin America, EMEA (Europe, Middle East, and Africa), and Asia Pacific regions) and China. Its products are classified into five categories. The Weight Management category includes meal replacements, protein shakes, drink mixes, weight loss supplements, healthy snacks, and metabolism-boosting teas. The Targeted Nutrition category features functional beverages and dietary supplements. The Energy, Sports, and Fitness category consists of products that support a healthy and active lifestyle. The Outer Nutrition segment offers facial skincare, body care, and hair care products. The Literature and Promotional Items include start-up kits, sales tools, and educational materials.

Employees
8,500
Headquarters
George Town
Listed
Dec 16, 2004
Sector
Consumer Staples
Industry
Personal Care Products

HLF key statistics

Market cap
1.40B
Price-earnings ratio
8.83
Dividend yield
—
Average volume
1.41M
Volume
1.33M
Open price
$13.60
High today
$13.76
Low today
$13.21
52 Week high
$20.40
52 Week low
$7.56

Herbalife (HLF) at a glance

As of Oct 23, 2026, Herbalife (HLF) shares are priced at $13.39, giving the company a market cap of 1.40B and a price-to-earnings ratio of 8.83.

Today the stock has traded between $13.21 and $13.76. The current price is 1.4% above the day's low and 2.7% below its high.

Volume so far is 1.33M shares, in line with the average of 1.41M shares a day.

Over the past year Herbalife has ranged from $7.56 to $20.40, and now sits 45% of the way up that range.

Herbalife met or beat analyst EPS estimates in 7 of the last 8 quarters. In Q2 FY26 it reported $0.51 per share against an estimate of $0.5414.

The average analyst price target is $18.36, 37.1% above the current price, from 5 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

60%of 5 analyst ratings say Buy
  • Buy60.0%
  • Hold40.0%
  • Sell0.0%
Price target · 5 analystsAvg $18.36
Low
$9.09
Now
$13.39
High
$26.25

HLF earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 7 of the last 8 quarters, by 36.8% on average.

  1. Q3 FY24: reported $0.57 per share against an estimate of $0.3543
  2. Q4 FY24: reported $0.36 per share against an estimate of $0.2219
  3. Q1 FY25: reported $0.59 per share against an estimate of $0.3707
  4. Q2 FY25: reported $0.59 per share against an estimate of $0.3863
  5. Q3 FY25: reported $0.50 per share against an estimate of $0.4656
  6. Q4 FY25: reported $0.45 per share against an estimate of $0.4308
  7. Q1 FY26: reported $0.64 per share against an estimate of $0.5794
  8. Q2 FY26: reported $0.51 per share against an estimate of $0.5414

HLF news

  • Snigdha Gairola

    FTC Sending $15.8 Million To 2.1 Million Cash Advance App Users: Here’s When Payments Begin

  • Press releaseBusiness Wire

    Herbalife to Participate in 1 on 1 Meetings at Maxim Growth Summit on October 14

  • Press releaseBusiness Wire

    Herbalife to Announce Third Quarter 2026 Results on November 2

  • Lekha Gupta

    Herbalife Launches $250 Million Stock Buyback

  • Press releaseBusiness Wire

    Herbalife Announces $250 Million Share Repurchase Program

  • Press releaseBusiness Wire

    Herbalife Reaffirms Third Quarter and Full Year 2026 Guidance

  • Press releaseBusiness Wire

    Herbalife Announces Planned CEO Transition

  • Press releaseBusiness Wire

    Herbalife to Participate in Fireside Chat at Barclays Global Consumer Conference on September 9

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.